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We present a novel and simple method for amplifying
RNA targets (named by its acronym, SMART), and for
detection, using engineered amplification probes that
overcome existing limitations of current RNA-based
technologies. This system amplifies and detects opti-
mal engineered ssDNA probes that hybridize to target
RNA. The amplifiable probe-target RNA complex is
captured on magnetic beads using a sequence-specific
capture probe and is separated from unbound probe
using a novel microfluidic technique. Hybridization
sequences are not constrained as they are in conven-
tional target-amplification reactions such as nucleic
acid sequence amplification (NASBA). Our engineered
ssDNA probe was amplified both off-chip and in a mi-
crochip reservoir at the end of the separation micro-
channel using isothermal NASBA. Optimal solution con-
ditions for ssDNA amplification were investigated.
Although KCl and MgCl2 are typically found in NASBA
reactions, replacing 70 mmol/L of the 82 mmol/L total
chloride ions with acetate resulted in optimal reaction
conditions, particularly for low but clinically relevant
probe concentrations (<100 fmol/L). With the optimal
probe design and solution conditions, we also success-
fully removed the initial heating step of NASBA, thus
achieving a true isothermal reaction. The SMART assay
using a synthetic model influenza DNA target sequence
served as a fundamental demonstration of the efficacy
of the capture and microfluidic separation system, thus
bridging our system to a clinically relevant detection
problem. (J Mol Diagn 2012, 14:328-335; http://dx.doi.org/
10.1016/j.jmoldx.2012.02.001)
Influenza is a widespread pathogen that results in ap-
proximately 36,000 deaths annually in the United States.1
Influenza comprises a variety of subtypes, which are
classified by the antigenic subtype of hemagglutinin (H1
to H16) and neuraminidase (N1 to N9) proteins ex-
pressed on the viral particles.2 Seasonal influenza is gen-
328erally caused by H1N1, H3N2, and H1N2 viruses,3
whereas the highly pathogenic avian flu is caused by the
H5N1 subtype.4 Recently, a novel, swine-derived recom-
binant variant of H1N1 virus resulted in a limited pandemic.5
A recurrent pandemic of influenza could result in millions of
deaths worldwide.6 Such a catastrophic event could be
avoided if rapid point-of-care diagnostics were available to
health workers at the source of the infection, such that they
could contain the infection before it spreads into the global
community.7,8 Additionally, rapid diagnosis of influenza
would prevent excessive antibiotic use, which leads to an-
tibiotic-resistant bacterial strains and is a large financial
burden because of the extra cost of otherwise unnecessary
treatment, hospitalization, and medication.9,10
A number of approaches have been investigated for
influenza diagnostics, but each has associated limitations.
Viral culture is specific and provides viable virus for further
testing,11 but requires 3 to 14 days for results, limiting its use
for rapid diagnostics.12 Immunospecific tests, such as rapid
antigen tests and immunofluorescence microscopy, lack
sensitivity and do not provide sequence-specific informa-
tion for subtyping.13 Viral nucleic acid amplification and
detection can generate subtype or strain-specific informa-
tion, but these tests are also complex and expensive. PCR
requires expensive benchtop thermal cyclers and trained
technicians.12 Nucleic acid sequence-based amplification
(NASBA) is faster than PCR for RNA amplification and com-
pares favorably with PCR for HIV RNA detection in clinical
samples,14,15 but it is limited by RNA secondary structure,
which makes primer design and multiplexing difficult. Hy-
bridization sites on long, clinically relevant RNA strands
require stringent oligonucleotide design, with only a small
fraction of sequences hybridizing efficiently to RNA.16 Poor
hybridization of ssDNA oligonucleotides complicates
primer design, so that many conserved regions are not
successful as NASBA priming sites. To combat these is-
sues, NASBA begins with a 65°C heating step before the
addition of enzymes to disrupt full-length RNA secondary
structure,17 and primer sites for NASBA reactions are typi-
cally 100 to 250 nucleotides apart, to avoid products with
inhibitory secondary structure.18
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microfluidic systems have shown improvements over
conventional benchtop techniques. These reactors de-
crease reagent use and further decrease energy con-
sumption of the isothermal system by decreasing the
reaction volume. Additionally, the small reaction volumes
inherent in microfluidic chips (10 nL to 2 L) concentrate
the target molecule of interest to improve primer binding
and reaction kinetics. A preliminary study showed the
efficacy of small (10 to 50 nL) reaction volumes in a
silicon-glass reaction chamber,19 followed by use of a
reactor containing 10 parallel 80-nL chambers that filled
by capillary action.20 A final reactor design contained 11
parallel channels with two separate chambers for each
heating step, separated by hydrophobic burst valves.21
The second chamber included dehydrated enzymes,
which were shown to function in a real-time NASBA re-
action on the addition of off-chip heated reagents and
primers. Although the full reaction was not run on-chip
(the sample was purified off-chip), and although the cap-
illary loading resulted in loss of sample, that study dem-
onstrated several advantages of a microfluidic diagnostic
system. The reactor was made to be simple, multiplexed,
automated, and shelf-stable and to consume fewer re-
agents and energy than its benchtop counterpart.21 An-
other assay integrated purification and amplification of
RNA using a polydimethylsiloxane (PDMS) chamber re-
actor.22 Two reactors were contained on one chip, which
would allow two RNA samples to be simultaneously purified
from bacterial lysate, mixed with reaction mix, heated,
mixed with enzyme, and detected real-time using se-
quence-specific molecular beacons. Both systems show
the ability of microfluidics to create a closed, efficient, au-
tomated system that can decrease technician time, human
error, and potential for contamination. Together, these stud-
ies have demonstrated the viability and advantages of in-
corporating a microfluidic platform with NASBA.
We propose a novel amplification method, SMART (the
acronym stands for “simple method for amplifying RNA
targets”), that both incorporates the advantages of mi-
crofluidics and avoids the limitations of NASBA (including
inhibitory secondary structure of the amplified RNA seg-
ment and constrained binding sites between 100 and 250
nucleotides apart). SMART achieves this goal by incorpo-
rating a binding step and a microfluidic separation step,
which allows the two hybridization sites to be located any-
where along the RNA target. Additionally, incorporation of
an engineered ssDNA probe allows the user to choose
amplifiable probe and primer sequences, which reduces
secondary structure and enables the user to optimize reac-
tion kinetics. It is important to note that the amplification step
in SMART does not directly amplify the starting RNA.
To demonstrate this novel method, experiments were
first performed off-chip to verify that the amplification step
created the expected nucleic acid products and to opti-
mize solution conditions. After verification of the optimal
amplifiable probe set and solution conditions, the optimal
amplifiable probe set and solution conditions were then
transferred to the microchip platform to investigate micro-
fluidic separation and amplification. The novel technique
investigated in the present study achieved separation ofbound probe from free probe by magnetically dragging
beads through a microfluidic channel. Optimal real-time
amplification and detection of the probe on-chip was also
investigated.
The SMART method uses two probes that bind to spe-
cific sequences within the target RNA, allowing investi-
gators to test for multiple characteristics of a pathogen,
such as subtype, drug resistance, and strain. The major
components of the SMART assay are presented in Figure
1. A capture step (Figure 1A) associates bound probe
molecules with a magnetic bead by hybridizing target
RNA to a capture probe, consequently improving speci-
ficity because of the additional binding site needed. The
sequence of the two flanking ends of the SMART probe
(Figure 1B) can be adjusted by the user to optimize
amplification reaction kinetics. Because of the high probe
amplification efficiency, separation via a microfluidic chip
platform is required to minimize contamination with un-
bound probe molecules. The assay therefore includes a
novel and simple method for separating unbound probe
molecules using a PDMS chip and a magnet (Figure 1C).
Capture sample is placed in well W1, and unbound probe is
separated by holding a magnet to the bottom of the micro-
chip and slowly moving it to well W2, dragging the bead-
nucleic acid complex through a large volume of buffer.
Amplification of the probe is performed via NASBA
(Figure 1D), starting with the ssDNA amplifiable probe (Fig-
ure 1B). As with standard NASBA procedures, two primers
are used in conjunction with three enzymes (AMV-RT, T7
RNA polymerase, and RNase H). We demonstrate amplifi-
cation both on-chip and off-chip (in a tube).
Materials and Methods
Design of Capture Probes, SMART Probes,
Primers, and Molecular Beacons
Custom oligonucleotides (Table 1) were purchased from
either Integrated DNA Technologies (Coralville, IA) or
Eurofins MWGOperon (Huntsville, AL). The probe portion
complementary to the H5 RNA target was chosen to be a
sequence that has been previously shown to bind to viral
RNA (vRNA).23 Sequences of the nucleic acid arms flank-
ing either side of the complementary portion were chosen
to minimize secondary structure. This was done by first
using an online folding tool, DINAMelt (DINAMelt Server,
RNA Institute, SUNY Albany, Albany, NY; available at
http://mfold.rna.albany.edu), to reject sequences with pre-
dicted excessive secondary structure. The optimal probe
and primer set was then chosen by finding the probe that
gave the greatest product yield as shown via gel electro-
phoresis after a 90-minute amplification step.
NASBA Reactions
The NASBA reaction was run in 200-L polypropylene
tubes, in transparent plastic cuvettes, and in 3-mm-diam-
eter PDMS microwells. Reaction volumes varied from 5 to
70 L. The base NASBA mix contained 40 mmol/L Tris
(pH 8.0), 12 mmol/L MgCl2 or (CH3COO)2Mg (MgOAc),
330 McCalla et al
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threitol, 1 mmol/L dNTP, 2 mmol/L rNTP, 0.2 mol/L each
primer, and 15% dimethyl sulfoxide at the final reaction
concentrations. Real-time amplification reactions also in-
cluded 50 nmol/L final concentration of molecular bea-
con. The base enzyme mix contained 1.6 U/L T7 RNA
polymerase, 0.325 U/L AMV-RT, 0.005 U/L RNase-H,
and 0.105 mg/mL bovine serum albumin (BSA) at the final
reaction concentrations. To test optimal solution condi-
tions, additional BSA and polysorbate 20 (Tween 20)
were added as indicated. Three different thermal scenar-
ios were used to test optimal heating conditions: heatingto 65°C for 5 minutes and cooling to 41°C for 5 minutes
before the addition of enzymes, heating to 41°C for 2
minutes before the addition of enzymes, and mixing the
reaction mix and enzymes at room temperature before
heating to 41°C. Off-chip heating was achieved using a
MyCycler thermal cycler (Bio-Rad Laboratories, Hercu-
les, CA) or a water bath housed within a fluorometer
(Photon Technology International, Birmingham, NJ). In-
well heating was achieved using a Thermal-Clear thin-film
heater (14.73  55.88 mm2; Minco, Minneapolis, MN)
affixed to the bottom of the microreactor (Figure 2A).
Figure 1. Schematics of the SMART assay. A:
Capture. Influenza vRNA is captured on mag-
netic beads (SMB) using a sequence-specific bi-
otinylated oligonucleotide (BCO). An amplifi-
able probe is also specifically captured on the
RNA molecule, and beads are washed to remove
unbound probe. BCO, biotinylated capture
oligo; SMB, streptavidin-coated magnetic bead.
B: Probe design. The amplifiable probe includes
a central sequence for vRNA hybridization and
two ends for primer hybridization designed to
minimize probe secondary structure. Seq, se-
quence; RC, reverse compliment. C: Separation
step. Beads are placed in well W1, and a magnet
is used to move them from the well to the chan-
nel. The magnet is then moved toward well W2,
moving the beads through a large volume of
buffer, effectively separating unbound probe
from the capture complex. A counterflow helps
this process. Beads are finally deposited in W2
and well mixed before being removed for off-
chip amplification or preparation for on-chip
amplification. D: Probe amplification. The 3=
arm of the probe binds to the first primer, which
contains the T7 promoter sequence. AMV-RT
elongates primer 1 to create a DNA:RNA hybrid,
which is converted to ssDNA by RNase H. Primer
2 binds and is elongated by AMV-RT, creating
dsDNA capable of transcription by T7 RNA poly-
merase. The resulting RNA binds to primer 2 and
AMV-RT creates a DNA:RNA hybrid. RNase H
degrades the RNA, leaving a copy of the ssDNA
amplifiable probe. The reaction is thus cyclic
and exponential.NASBA reactions were run at 41°C for 90 minutes, and
. Bold re
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con fluorescence and by diluting the sample 1:5 in RNase-
free water and running gel electrophoresis (Small RNA kit;
Agilent Technologies, Santa Clara, CA).
PDMS Reactor Fabrication
Masks were created using AutoCAD software version
2011 (Autodesk, San Rafael, CA) and negative masks
were printed at 20,000 dots per inch (CAD/Art Services,
Bandon, OR). Photoresist (SU-8 100; MicroChem, New-
ton, MA) was spin-coated at a thickness of 120 m onto
silicon wafers [diameter 2 inches (5.08 cm)], prebaked
at 65°C, soft-baked at 95°C, and exposed to UV light in
the presence of the negative mask to selectively cross-
link channels. The wafer was then baked again, placed in
SU-8 developer to remove non-cross-linked SU-8, and
cleaned using isopropanol. The resulting master mold
was used to create PDMS microfluidic reactors (Figure 2,
A and B). Sylgard 184 elastomer base was mixed 1:10
with curing agent (Dow Corning, Midland, MI), poured
over the mask, and cured for 1 hour at 75°C. Holes 3 mm
in diameter were punched into the PDMS reactor to form
wells. The PDMS reactor and a 1-mm-thick soda-lime
glass slide (Corning, Corning, NY) were cleaned with
ethanol and treated with plasma for 1 minute 40 seconds
using a Harrick 32G plasma cleaner under vacuum [30 in
Hg (101.59 kPa)] at high radio frequency (Harrick
Plasma, Ithaca, NY). The channels were placed face
Table 1. Oligonucleotides Used in the SMART Method
Oligo
Amplifiable probe 5=-TCAAGAGTAGACACAGGATCAGC
Capture probe /5BioTEG/5=-ATGGTAGATGGTTG
Beacon [6FAM] 5=-CGTAGGCAATAGATG
Primer 1 (optimal) 5=-AATTCTAATACGACTCACTATAG
Primer 1 (alternate) 5=-TAATACGACTCACTATAGGTGAC
Primer 2 5=-TCAAGAGTAGACACAGGATCAGC
ssDNA target-H5 5=-GTGACTCCATCTATTGCCTAAAA
ssDNA target-H3 5=-ATTCCCTCCCAACCATTTTCTAT
Probes, primers, and molecular beacon used in the NASBA reactions t
with H5-binding sites was used. The H3 ssDNA target contains binding si
identification. The amplifiable probe sequence is conserved in 93.6% of
of all sequenced human H5 strains. The beacon contains a FAM molecule
region in the amplifiable probe corresponds to a binding site in H5 vRNA
to the T7 RNA polymerase promoter.down onto the glass slide, forming an irreversible bond
between the plasma-treated glass and PDMS. Baking the
PDMS reactor at 70°C for at least 30 minutes after joining
appeared to improve the glass-PDMS bond.
Capture of Target Synthetic ssDNA
The short synthetic strand of ssDNA, amplifiable probe
(Eurofins MWG Operon), and a biotinylated H5 capture
probe (Integrated DNA Technologies) (Table 1) were
mixed in a hybridization buffer composed of 20 mmol/L
Tris (pH 8.0), 20 mmol/L MgCl2, 150 mmol/L NaCl, 0.02%
Tween 20, and 1 mg/mL BSA. A negative control sample
contained an ssDNA target specific for H3 vRNA, and a
bead control contained only the capture probe. The mix-
tures were heated to 70°C for 2 minutes and cooled to 4°C
for 5 minutes before the addition of 2.8-m-diameter Invit-
rogen M-280 magnetic beads (Life Technologies, Carls-
bad, CA) for a final volume of 20 L. The samples were then
incubated at room temperature for 35 minutes. Beads were
collected at the bottom of the tube using cylindrical neo-
dymiummagnets (K&JMagnetics, Jamison, PA), and 18L
of the supernatant was removed before transfer of the
beads to the microfluidic separation platform.
Separation of Probe Complex
Separation of the bead-probe complex (Figure 1A) from
free amplifiable probe molecules (Figure 1B) was
Sequence
CAATAGATGGAGTCACGTAATCAGATCAGAGCAATAGGTCA3=
GGTA-3=
ACTACG-3= [BHQ1a6FAM]
AGGTGACCTATTGCTCTGATCTGATTAC3=
GCTCTGATCTGATTAC3=
CCCATACCAACCATCTACCAT-3=
AAAACACATCATAAGGGTAACAGTTGCTG-3=
5 vRNA, but for this proof-of-concept work, a short ssDNA synthetic target
ific for H3 vRNA, which serves as a negative control for H5 ssDNA target
enced human H5 strains, and the capture probe is conserved in 89.3%
5= end and a black hole quencher molecule on the 3= end. The italicized
gions are the primer 1 binding sites. The underlined region corresponds
Figure 2. Chip design for microfluidic separa-
tion and on-chip amplification. A: Schematic of
chip design. Beads are placed in well W1, and a
magnet is pulled from well W1 to W2, washing
unbound probe from the capture complex (Fig-
ure 1A). A wider opening at W1 allows beads to
enter the channel more easily. Dashed box in-
dicate the location of a heating device, and an X
indicates the thermocouple position; both are
used for on-chip amplification temperature con-
trol. B: Photo of chip. Wells and channels are
filled with dye to enhance contrast. Scale bar 
1 cm.ATAGG
GTATG
GAGTC
GGAGA
CTATT
AT-3=
AAATA
GAAAA
arget H
tes spec
all sequ
on the
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Reactor cleaning and preparation was achieved by pres-
surizing the well with a 1-mL syringe, then flushing the
channels with nuclease decontamination solution, fol-
lowed by flushing three times with nuclease-free water
(Integrated DNA Technologies, Coralville, IA) and finally
flushing two times with priming buffer (1 mg/mL BSA,
0.1% Tween 20). The microchips were stored at 4°C for at
least 14 hours. To set up a counterflow, well 2 (W2; Figure
2A) contained 12 L of priming buffer, well 1 (W1; Figure
2A) contained 2 L priming buffer, and the chip was held
at an approximately 15-degree tilt toward W1. Beads
were placed in W1 and moved through the channel by
moving a neodymium magnet along the bottom of the
channel at 1 mm/second. When beads were 1 cm
from W2, the flow was stopped by the removal of solution
in both W1 and W2 and the addition of 12 L of paraffin
oil to W1. For off-chip amplification experiments, the so-
lution in W2 was replaced with 5 L of fresh priming
solution. Beads were then pulled into W2, collected in a
polypropylene tube, and W2 was rinsed with an addi-
tional 6 L of priming buffer. The beads were then col-
lected at the bottom of the tube and all but 2 L of
solution was removed for downstream NASBA reactions.
For on-chip amplification experiments, the solution in W2
was replaced with a NASBA reaction mix that included
free probe molecules, and beads were pulled into W2.
In-Well Real-Time Probe Amplification
Real-time amplification of ssDNA probe was conducted
in a microwell using NASBA mix without separation, such
that the ssDNA probe was included in the NASBA mix
and added directly to microwell W2 (Figure 2A). To mimic
SMART reaction conditions, in-well probe amplification
included beads from a bead control capture reaction and
a subsequent separation step as described above. The
reactor channel contained priming solution and 12 L of
paraffin oil in W1. The reactor W2 contained 5 L NASBA
mix (after the addition of 0.4 L sample mix) and 5 L
paraffin oil, to avoid sample evaporation. An adjacent
reactor channel contained identical solution conditions
and W1 contents, but had 5 L of priming solution and 5
L of paraffin oil in W2. A Minco Thermal-Clear thin-film
heater (14.73 mm  55.88 mm2) was affixed to the bot-
tom of the reactor and centered under the reactor well
and the adjacent well (Figure 2A). A type K thermocouple
(Omega Engineering, Stamford, CT) was placed in the
adjacent well to accurately determine fluid temperature in
the wells. An external power supply (RK-80H; Matsusada
Precision, Kusatsu City, Shiga, Japan) provided 4 to 5 V
to the heater to achieve 41°C in the well. The reactor was
placed under a Nikon Eclipse TE300 fluorescent micro-
scope (Nikon Instruments, Melville, NY) with a blue filter
set (450 to 490 nm excitation, 515 nm long-pass emis-
sion), a 4 objective, a photomultiplier detection system
with a gain of 700 V (model 814; Photon Technology
International, Birmingham, NJ), and an integrated high
speed shutter (Melles Griot, Albuquerque, NM) set to
open for 0.2 seconds. A custom in-house data acquisition
program written using LabVIEW version 8.6 (National In-struments, Austin, TX) collected photomultiplier tube out-
put at a rate of 12 to 15 Hz.
Results
Off-Chip Probe Amplification and Optimization
We first validated that the amplification reaction worked
as designed, yielding expected products. To investigate
this, combinations of starting material, including amplifi-
able probe, primers (primer 1 alternate and primer 2;
Table 1), and dsDNA, were first characterized by small-
RNA gel electrophoresis to find their expected peaks and
bands on an electropherogram plot. In addition, the ds-
DNA was transcribed under NASBA conditions with T7
RNA polymerase to find the expected band for the RNA
product. Given this information, a series of tests varying
the presence of enzymes with amplifiable probe and
primers in NASBA conditions were performed to verify the
full NASBA amplification. Three conditions were used:
AMV-RT only, both AMV-RT and T7 RNA polymerase, and
all three enzymes (Figure 3A). For all conditions, runs
were performed using KCl NASBA buffer with a 65°C/
41°C heating step before amplification. Analysis was per-
formed using gel electrophoresis. Outcomes of the ex-
periment confirmed that the amplification reaction was
occurring as expected (Figure 3A). One important note is
that the product contains several peaks of varying length.
These peaks are all confirmed to be products, because
they appear when the corresponding cDNA is tran-
scribed in NASBA conditions with only T7 RNA polymer-
ase present. We believe that these alternate peaks occur
as the polymerase prematurely aborts transcription. This
does not affect the detection methods, however, because
the beacon targets the middle of the transcribed RNA
and thus needs only roughly the first 45 to 50 nt to
successfully detect the product. No other nucleic acid
species appear within the range of the RNA transcribed.
Before we performed the remaining experiments, the prim-
ers themselves were modified to yield the maximum prod-
uct RNA. The resulting primer set was comprised of primer
1 (optimal) and primer 2 (Table 1). These optimal primers
were used for the remaining experiments.
A study to inspect the effect of replacing chloride ions
with acetate ions was also conducted, to optimize
NASBA for our application. To achieve this, an experi-
ment was performed under four amplification conditions
and with the base NASBA mix adjusted: i) a positive
control; ii) replacing KCl with KOAc; iii) replacing MgCl2
with MgOAc; and iv) replacing both KCl and MgCl2 with
acetate complements. Samples were subjected to 65°C/
41°C heating steps before amplification, and they were
analyzed using gel electrophoresis. Replacing all of the
chloride salt with acetate salt increased product yield,
but a combination of 70 mmol/L acetate and 12 mmol/L
chloride salts yields the optimum balance for these four
conditions (Figure 3B).
Because gel electrophoresis allows only for endpoint
quantification, the previous result was investigated fur-
ther to ensure that this method leads to an improvement
1°C hea
, arbitr
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experimental sample replacing KCl with KOAc were pre-
pared. After initial heating steps of 65°C followed by 41°C
were performed in a thermal cycler, each sample was run
in a fluorometer for a 90-minute amplification reaction.
The acetate sample had a faster initial rising time than the
chloride sample, even though the chloride sample had a
faster exponential phase (Figure 3C). The data support
using KOAc in place of KCl, because use of KOAc yields
faster results during real-time amplification.
On-Chip Probe Amplification and Optimization
A microfluidic assay for the separation and amplification of
bound probe molecules aims to simplify and streamline
influenza detection, as well as to save energy and reagents.
The removal of the initial 65°C heating step shortens the
overall assay time, decreases the energy required to oper-
ate the device, and simplifies the heating implement nec-
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mmol/L KOAc) did not appear to affect real-time amplifi-
cation at these levels, and a linear amplification could
again clearly be seen for both 1 pmol/L and 100 fmol/L
free amplifiable probe. Increasing concentrations of ei-
ther chloride or acetate ions lead to decreased transcrip-
tion rates by T7 RNA polymerase, but the polymerase is
more sensitive to chloride ions than acetate ions.24 Be-
cause the amplification reaction is cyclical, a decrease in
efficiency at any given step is more pronounced at lower
concentrations; this could explain the benefit of using
KOAc in place of KCl at lower concentrations of initial
probe. It may also imply that the change of anion in-
creased the combined efficiency of AMV-RT and RNase
H in the steps crucial to the cyclic portion of amplification.
In addition, it is possible that nonspecific primer-dimers
occur in our system, particularly given the low operational
temperature and long priming sequences required. A low,
clinically relevant probe concentration with delayed ampli-
fication may be inhibited by excessive primer-dimer forma-
tion. This is particularly problematic when enzyme mix is
added at room temperature. Although amplification can
proceed at low probe concentrations if enzymes are added
before heating the NASBA mix to 41°C, it may be advanta-
geous to heat the sample to the reaction temperature before
the addition of enzymes. These data imply that optimal
solution conditions for in-well amplification of low concen-
tration probe molecules include replacing KOAc with KCl.
In-well kinetics may also differ from benchtop reac-
tions, because of the contact of the reaction with PDMS
and with paraffin oil. PDMS is the main component of our
microfluidic device (Figure 2), and paraffin oil is present
to prevent sample evaporation and contamination in the
reactor. Proteins have been shown to adsorb to PDMS25
and at oil/water interfaces,26 which could sequester en-
zyme in our system. To determine whether enzyme ad-
sorption adversely affects in-well reaction kinetics,
NASBA reactions were performed using an additional 1
mg/mL BSA and 0.02% Tween 20 in the reaction mix. To
prevent primer-dimer pairs, the reaction mix was heated
to 41°C before the addition of enzymes. Reaction kinetics
were aided by the addition of BSA and Tween (Figure
4C), likely because of BSA adsorption to the hydrophobic
regions of the PDMS and oil/water interface.
Capture and Amplification of Probe via SMART
Assay
After determining optimal reaction conditions for in-well
probe amplification, we tested the ability of the system to
operate from the capture step to the amplification and
detection step. Synthetic H5 ssDNA (1 pmol/L) was cap-
tured with 2 pmol/L each of amplifiable probe and cap-
ture probe. A negative control reaction contained syn-
thetic H3 ssDNA, and a bead control contained only
capture probe (Table 1). After microfluidic separation
from free probe molecules, the beads were removed from
W2 (Figure 2A) and collected, and all but 2 L of fluid
was removed from the sample. The beads were trans-
ferred to a downstream 15-L NASBA reaction; the beadcontrol received 1 pmol/L total of amplifiable probe, to
ensure that the beads and the solution conditions from
the microfluidic separation did not inhibit the downstream
reaction. A positive control (1 pmol/L amplifiable probe)
and negative control (0 pmol/L amplifiable probe) were
also run, to ensure that the reaction chemistry was robust.
The samples were heated to 65°C and cooled to 41°C
before the addition of enzymes, and the reaction was run for
90 minutes. The reactions were quantified on a small-RNA
gel electrophoresis chip. The bead control did not differ
notably from the positive control. A representative example
of the H5 probe amplification after capture, with the elec-
tropherogram, is shown in Figure 5. The sample containing
the target molecule (H5) contained 7430 pg/L total prod-
uct RNA, whereas the sample containing a false target (H3)
contained 1155 pg/L total RNA. The negative control con-
tained no visible product RNA. Although the small peak in
the H3 amplification sample indicates nonspecific amplifi-
able probe adsorption, this small peak corresponds to a late
amplification rise in the exponential NASBA kinetics, with a
small rise at the end of 90 minutes.
Discussion
Experiments showed that the polymerase prematurely
aborts transcription, and thus the SMART method re-
quired optimization of primers and buffer components to
reduce the population of aborts and to maximize reaction
kinetics. As already noted, the detection scheme for in-
fluenza RNA was not affected by these aborts. It is im-
portant to note that the anions (chloride or acetate) af-
fected the combined efficiency of AMV-RT and RNase H
in the amplification. Similarly, addition of enzyme at re-
action temperature and adsorption of enzymes to PDMS
were important factors in understanding the amplification
efficiency. The SMART system was robust at determining
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Figure 5. Probe sensitivity with capture of functional RNA (fRNA): Amplifi-
cation of probe captured in hybridization buffer. The 90-minute amplification
of 1 pmol/L (1.2  107 copies total) captured fRNA with an original 2 pmol/L
free probe concentration, separated on-chip, amplified off-chip, and de-
tected by diluting 1:5 and running on an RNA gel. Although there is a large
drop in amplification of the negative control sample, a small peak in the
negative control capture electropherogram (inset) shows evidence of non-
specific probe adsorption.
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JMD July 2012, Vol. 14, No. 4the presence of target molecules, particularly when the
sample was run for 90 minutes. The nonspecific ad-
sorption may be further decreased by lengthening the
separation and washing step by extending the length of
the channel or manipulating the solution conditions dur-
ing capture or separation.
Here, we have demonstrated a novel method for am-
plification and detection of RNA targets by using ampli-
fiable probes that are engineered to optimize reaction
kinetics. The reaction products, kinetics, and chemical
conditions were studied using both off-chip and on-chip
amplification and detection systems. An optimal amplifi-
cation probe was chosen, and optimal ion concentrations
were determined by replacing potassium chloride with
potassium acetate. Furthermore, we showed that given
these optimized conditions, the initial 65°C step can be
eliminated, making the amplification fully isothermal and
thus providing significant advantages in field and other
point-of-care settings. The hybridization of both a capture
and amplifiable probe increases specificity of the assay,
and the use of magnetic beads allows for separation of the
target-bead complex from unbound amplifiable probe. Our
method includes a simple microfluidic reactor to facilitate
the separation step. Amplification in wells was shown to
have rapid detection at 1 pmol/L and 100 fmol/L with re-
duced reagent use, requiring only 5 L of reaction volume.
Additionally, the small reaction volume concentrates the
target and probe molecules, which may decrease the time
to positive. We have also demonstrated capture, on-chip
separation, and off-chip amplification. Although evidence
existed for nonspecific binding of amplification probe, there
was a distinct decrease in signal with endpoint quantifica-
tion, which corresponds to a large difference in time to
positive in real-time quantification for on-chip amplification.
This platform is clinically relevant, given that the probes
presented were based on sequences shown to hybridize to
full-length influenza A H5 vRNA. Additionally, because of the
flexibility of the amplifiable probe sequence, this method can
easily beused for detection of any number of RNA targets. The
present work thus provides a fundamental basis for a novel
and simple general method for RNA detection.
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